LianBio
ClosedShanghai, China · Founded 2020 · $313.0M raised
- Headquarters
- Shanghai
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- lianbio.com
- Total Funding
- $313.0M
- Last Round
- $3.0M Venture RoundOct 2020
- Rounds
- 2
About
LianBio was a Shanghai-based biotechnology company launched in 2020 by Perceptive Advisors to license and commercialize innovative therapies for patients in China and major Asian markets. The company went public on Nasdaq in 2021 but announced a wind-down of operations following a strategic review completed in February 2024.
Summary
LianBio is a Biotech company based in Shanghai, China, founded in 2020. It has raised $313.0M in total across 2 rounds, most recently a $3.0M Venture Round in Oct 2020. Investors include RA Capital Management, Venrock and Pfizer Ventures.
Funding History
Oct 2020
Sign up to see all 2 events
Funding: Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lianbio"><img src="https://indexed.vc/api/badge/company/lianbio" alt="LianBio on Indexed.vc" width="260" height="76" /></a>